TOADS Study: TO Assess Death From Septic Shock.
TOADS
Epidemiological Survey of Death Modalities in Patients With Septic Shock Referred to French Intensive Care Units: TOADS Study.
1 other identifier
observational
340
0 countries
N/A
Brief Summary
The aim of this study is to assess the causes of death in patients with septic shock in French intensive care units. It is an epidemiologic and descriptive study .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2015
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2015
CompletedStudy Start
First participant enrolled
September 1, 2015
CompletedFirst Posted
Study publicly available on registry
September 11, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedSeptember 11, 2015
September 1, 2015
8 months
July 8, 2015
September 9, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome of this study is to identify the reasons of death of patients with septic shock via a questionnaire.
Recording of the context and the cause of death with a questionnaire
Patients will be followed during their hospital stay, with a maximal follow up of 90 days
Interventions
There is no intervention as it is a pure observational study for epidemiologic survey.
Eligibility Criteria
Consecutive patients who had died of septic shock
You may qualify if:
- Adult patient
- Died of septic shock in the intensive care unit (ICU)
- At least 6 hours of vasopressors
You may not qualify if:
- Legally protected adult patient.
- Less than 6 hours of vasopressors
- Opposition to participation in the study expressed by the patient, family or person of trust
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pierre ASFAR, MD-PhD
University hospital, Angers, FRANCE
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2015
First Posted
September 11, 2015
Study Start
September 1, 2015
Primary Completion
May 1, 2016
Study Completion
May 1, 2016
Last Updated
September 11, 2015
Record last verified: 2015-09